The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...

GlaxoSmithKline has found a replacement for head of vaccines R&D Emmanuel Hanon, who left the company for a US biotech earlier this year, hiring Phil Dormitzer from ...

Berenberg Bank analyst Kerry Holford maintained a Hold rating on Hochschild Mining (HOC – Research Report) yesterday and set a price target of ...

GlaxoSmithKline places its shingles vaccine Shingrix among its top prospects, with peak sales potential of almost $6 billion. Now, Pfizer and BioNTech are joining forces to try to grab a slice of ...

The MRHA, which overseas the safety of medicines, vaccines and healthcare devices, was accused of not acting fast enough when ...

MHRA’s independence also questioned during Commons debate, with regulator accused of being too close to companies it ...

Ischemic stroke market Insights: Rising prevalence of ischemic strokes boosts demand for effective treatment and prevention strategies.

Dr Alexopolous has received research grants from Cephalon and Forest Laboratories and is on speakers bureaux for Cephalon, Forest, Bristol-Myers Squibb, GlaxoSmithKline, Pfizer and Janssen.

They call themselves Speed to Market, a group of life sciences and real estate professionals who find, build and sell manufacturing space for biotech employers around Philadelphia. During the COVID ...